Perceived Diabetes Burden, Clinical Care Gap, and Intent to Prescribe a Diabetes Polypill to Indian Patients with Type 2 Diabetes
Most HCPs considered CVD risk management and adherence to medication as serious challenges and intended to prescribe an affordable and efficacious diabetes polypill to patients with T2D to lower CVD risk.
Authors
- Indranil Bhattacharya (ORCID: https://orcid.org/0000-0002-6074-6272)
- Maithri Singh
Institutions
- Eli Lilly (United States) (US)
- IQVIA (India) (IN)
- Eli Lilly (India) (IN)
Publication Details
- Journal
- Diabetes Metabolic Syndrome and Obesity
- Published
- 2026-02-01
- DOI
- https://doi.org/10.2147/dmso.s547492
- Primary Topic
- Medication Adherence and Compliance
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Eli Lilly and Company